Sixth S-1 amendment fixes the IPO price at $4 for a $15 million Nasdaq raise
Veri MedTech's sixth amendment locks the price at a flat $4 for 3.75 million shares, a $15 million raise with Network 1 Financial Securities running the book. A fixed price rather than a range usually means the deal is close to done, so the Nasdaq debut is the next thing to look for.
Source: SEC filing



